This inventor holds 4 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Morphic Therapeutic, Inc.. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: The Innovations of Inventor Qi Qiao
Introduction
Qi Qiao is a notable inventor based in Natick, MA (US). He has made significant contributions to the field of medical research, particularly in the development of small molecule inhibitors. With a total of 4 patents to his name, his work has the potential to impact the treatment of various diseases and conditions.
Latest Patents
Qi Qiao's latest patents focus on inhibiting the αvβ6 integrin. The first patent discloses small molecule inhibitors of αvβ6 integrin, along with methods for using them to treat a range of diseases. The second patent similarly addresses small molecule inhibitors of αvβ6 integrin, emphasizing their therapeutic applications.
Career Highlights
Qi Qiao is currently employed at Morphic Therapeutics, Inc., where he continues to innovate and develop new therapeutic solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Some of Qi Qiao's notable coworkers include James E. Dowling and Dawn M. Troast, who contribute to the collaborative environment at Morphic Therapeutics, Inc. Their combined expertise fosters innovation and drives the company's research initiatives.
Conclusion
In summary, Qi Qiao is an accomplished inventor whose work in small molecule inhibitors has the potential to transform medical treatments. His contributions to the field are significant, and his ongoing research at Morphic Therapeutics, Inc. promises to yield further advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile